Director of Communications
The two San Francisco organizations signed an affiliation agreement to increase research collaboration
SAN FRANCISCO (October 26, 2022) – Gladstone Institutes and the Chan Zuckerberg Biohub (CZ Biohub) signed an affiliation agreement to increase their research collaboration. The two San Francisco organizations, both located in the Mission Bay neighborhood known for being a hub for health and biotech, will partner to uncover the fundamental mechanisms of disease in order to find new prevention strategies, treatments, and cures.
“For decades, Gladstone has distinguished itself as a top biomedical research institution, and Biohub scientists have regularly collaborated with Gladstone’s talented researchers,” said Joe DeRisi, Ph.D., CZ Biohub president. “This new affiliation will make these exchanges even more robust and productive.”
Gladstone researchers are eligible to apply to become CZ Biohub Investigators, and as part of the new agreement, those selected can use Biohub’s funding to support their research both at Gladstone’s and Biohub’s scientific facilities.
“Both Gladstone and Biohub are focused on supporting the boldest and riskiest ideas, knowing these will lead to the most disruptive solutions to overcome unsolved diseases,” said Deepak Srivastava, M.D., president of Gladstone. “It’s exciting to join forces so we can achieve our common missions.”
The new affiliation agreement enables Gladstone investigators who are appointed as CZ Biohub Investigators to have access to resources to participate in research at both organizations. These investigators can also hire postdoctoral fellows and staff to work at the Biohub’s facilities to support their science.
Current Chan Zuckerberg Biohub Investigators at Gladstone include virologist Melanie Ott, M.D., Ph.D.; data scientist Katie Pollard, Ph.D.; and bioengineer Seth Shipman, Ph.D.
“CZ Biohub is known for being exceptionally collaborative, which is a value we share at Gladstone,” says Gladstone Chief Operating Officer, Robert Obana, MBA. “By combining our unique strengths, I believe we will successfully accelerate the pace of our discoveries and help make a substantive impact on medicine and healthcare through our research.”
About Gladstone Institutes: To ensure our work does the greatest good, Gladstone Institutes focuses on conditions with profound medical, economic, and social impact—unsolved diseases. Gladstone is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease.
About CZ Biohub: The Chan Zuckerberg Biohub is a nonprofit research center that brings together physicians, scientists, and engineers from Stanford University; the University of California, Berkeley; and the University of California, San Francisco. Working at CZ Biohub are some of the brightest, boldest engineers, data scientists, and biomedical researchers who together with our partner universities seek to understand the fundamental mechanisms underlying disease and develop new technologies that will lead to actionable diagnostics and effective therapies.
Gladstone Institutes: Julie Langelier | email@example.com | 415.734.5000
CZ Biohub: Julie Chao | firstname.lastname@example.org | 415.816.5571
Stay up-to-date on the latest news, publications, competitions, and stories from CZ Biohub.
FOR IMMEDIATE RELEASE SAN FRANCISCO — Sept. 17, 2018 — The Chan Zuckerberg Biohub (CZ Biohub), a nonprofit medical research organization, has hired ...
New funding from CZ Biohub fosters further scientific research collaboration between Stanford; University of California, Berkeley; and University of ...
New open-source, cloud-based tool rapidly interprets terabytes of data to detect disease-causing pathogens In an ongoing pilot project and partnership with the ...